Amura Technologies Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 3

Amura Technologies General Information

Description

Designer of peptides. The company provides computational screening and design of small molecules to enable rapid identification of novel molecules for client companies.

Contact Information

Website
www.proteom.com
Formerly Known As
Proteom
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Babraham Hall
  • Babraham
  • Cambridge CB2 4AT
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amura Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amura Technologies‘s full profile, request access.

Request a free trial

Amura Technologies Executive Team (4)

Name Title Board Seat Contact Info
Gareth Roberts Co-Founder & Chief Executive Officer
Raymond Fagan Co-Founder
You’re viewing 2 of 4 executive team members. Get the full list »

Amura Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Amura Technologies‘s full profile, request access.

Request a free trial